Article and Video CATEGORIES
Amy brings over three decades of experience in for-profit and nonprofit business management and ownership. In December 2017, she joined The Global Resource for Advancing Cancer Education as its Executive Director. She directs its growth in strategy, revenue, outreach, partnership, and programs.
We couldn't do what we do without you, our volunteers!
From helping at the ASCO booth, admin and transcription work, to spreading pamphlets and information about GRACE, we have been lucky enough to meet some of the most amazing people.
This month we are pleased to give a gracious nod and a huge thank you to Patrick Moroney. We first met Patrick at ASCO 2018 when he offered to help us work the booth at the yearly Chicago event.
Pat Moroney lives in the Chicago area with his wife Eileen, who has been battling stage IV ALK+ Non-Small Cell Lung Cancer for over three years. Pat and Eileen have found GRACE indispensable in preparing for oncology appointments and staying current with ever-changing treatment options. In the past year, Pat has been promoting GRACE resources at area hospitals, a local Caregiver Support Group at the cancer-focused Wellness House, and recently as a Caregiver Mentor with Imerman Angels. This June GRACE was honored to have both Pat and Eileen support the GRACE Team at the recent ASCO 2019 conference in Chicago, Illinois.
Patrick and Eileen - we thank you! And we hope to see you again next year, and for many years to come!
The GRACE Staff
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Hello Linda, my name is Alexandra Beneke, I'm the Outreach Manager for GRACE. Your willingness to share your experiences and knowledge with the cancer community is truly inspiring. Your dedication to...
Recent Comments
That's…